Effect of celecoxib combined with thoracic epidural analgesia on pain after thoracotomy

Br J Anaesth. 2010 Aug;105(2):196-200. doi: 10.1093/bja/aeq129. Epub 2010 Jun 25.

Abstract

Background: Thoracotomy results in severe postoperative pain potentially leading to chronic pain. We investigated the potential benefits of oral celecoxib on postoperative analgesia combined with thoracic epidural analgesia (TEA).

Methods: Forty patients undergoing thoracotomy were included in this prospective, randomized, double-blind, placebo-controlled study. General anaesthesia was standardized. Patient-controlled epidural analgesia (T4-T5) was used during 48 h after surgery (ropivacaine 2 mg ml(-1) with sufentanil 0.5 microg ml(-1)). Patients were allocated to receive oral celecoxib or placebo from the evening before surgery until 48 h after operation. Postoperative pain scores, respiratory function, and morbidity were compared between the two groups.

Results: Postoperative pain scores at rest (P=0.026) and during coughing (P=0.021) were lower and patient satisfaction was greater (P=0.0033) in the celecoxib group. Consumption of the local anaesthetic solution was comparable between groups. Postoperative restrictive pulmonary syndrome and morbidity were comparable between groups.

Conclusions: Celecoxib improves postoperative analgesia provided by TEA after thoracotomy.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Analgesia, Epidural / methods*
  • Celecoxib
  • Cyclooxygenase 2 Inhibitors / administration & dosage*
  • Double-Blind Method
  • Female
  • Forced Expiratory Volume / drug effects
  • Humans
  • Male
  • Middle Aged
  • Pain Measurement / methods
  • Pain, Postoperative / etiology
  • Pain, Postoperative / prevention & control*
  • Patient Satisfaction
  • Prospective Studies
  • Pyrazoles / administration & dosage*
  • Sulfonamides / administration & dosage*
  • Thoracotomy / adverse effects*
  • Vital Capacity / drug effects
  • Young Adult

Substances

  • Cyclooxygenase 2 Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Celecoxib